I’ve always found the parallels between my life as an IVF specialist and my role as an angel investor fascinating. At first glance, the worlds of medicine and startups might seem poles apart. However, the more I immerse myself in both, the more I realize how my medical practice informs my investment decisions. The ability to spot promising startups is not just a knack but a skill honed over years of diagnosing patients and navigating the complexities of healthcare.
In medicine, every patient is a unique puzzle. As an IVF specialist, I’ve learned to trust my instincts, honed by years of practice, to interpret subtle signs and symptoms. In the startup world, founders present their visions much like patients describe their symptoms. It’s my job to listen, to see beyond the pitch, and to discern the potential beneath the surface noise. An entrepreneur’s passion is akin to a patient’s hope—a powerful motivator but one that needs to be grounded in reality.
I recall a particular case from my clinic. A couple came in, desperate for a solution after years of trying to conceive. They were anxious, overwhelmed, and somewhat skeptical. Yet, they were open to learning and adapting. In much the same way, a founder I recently met was navigating the tumultuous waters of early-stage startup life. His startup wasn’t about reinventing the wheel but about making a real impact in an underserved segment. He listened more than he spoke, absorbed feedback, and demonstrated a willingness to pivot—qualities that reminded me of that resilient couple.
In both IVF and investing, the stakes are high. Decisions have profound implications. As an IVF doctor, I’ve learned the art of balancing risk with reward, a skill that directly applies to investing. The ability to assess risk is crucial, whether deciding on a fertility treatment plan or choosing to back a startup. In my experience, startups often forget the nuanced understanding of risk that IVF treatments have taught me. Risk in medicine is calculated, mitigated, and always patient-centric. Similarly, in investing, risk must be evaluated with a clear understanding of its potential impact on the business and its stakeholders.
Startups are inherently chaotic, much like the early stages of an IVF cycle. Yet, within this chaos lies the potential for creation and growth. The unpredictability is what keeps me engaged. Every entrepreneur is jumping into the unknown with both feet, much like patients embarking on an IVF journey. They hope for success, but they must also be prepared for setbacks. This emotional resilience is something I admire and a trait that, in my opinion, startups should learn from IVF patients.
One might wonder about the practical aspects of this crossover. How does my medical practice concretely influence my investment choices? For one, I bring a disciplined, methodical approach to evaluating startups. Medicine is grounded in routine and reproducibility, essential for ensuring predictable outcomes. Similarly, when evaluating a startup, I focus on processes and systems rather than just the product or vision. Is the team capable of executing their plan? Do they have a system in place to address potential failures? These questions are crucial and often overlooked by investors who are swayed by charismatic pitches.
Despite the structured nature of medicine, it teaches you to expect the unexpected. Every patient reacts differently to treatment. This unpredictability is mirrored in startups. Just as a surgeon must be ready to pivot during an operation, a founder must be agile enough to respond to market shifts or internal challenges. This adaptability is a critical factor in my investment decisions. A startup that shows an ability to pivot thoughtfully and decisively is one I’m more likely to back.
Communication is another critical area where my experience as a doctor proves invaluable. The doctor-patient relationship is built on trust, transparency, and clear communication. Similarly, as an investor, I seek founders who communicate openly, who are not afraid to share both their successes and their failures. This transparency builds trust, a foundation upon which successful businesses are built.
The most rewarding aspect of bridging these two worlds is the opportunity for learning and growth. Medicine and startups both demand a lifelong commitment to learning. In my clinic, I’m constantly learning about new treatments and technologies, much as I learn about emerging trends and innovations in the startup ecosystem. This continuous learning keeps me engaged, curious, and ever-evolving, both as a doctor and an investor.
Despite the differences, the similarities between my roles in medicine and investing are striking. It’s about spotting potential, understanding risk, being adaptable, and communicating effectively. These skills are not exclusive to one domain but are transferable and mutually reinforcing. My journey in medicine deepens my understanding of startups, and my experiences with startups enrich my medical practice.
In the end, it’s about the human element. Whether it’s a patient in my clinic or a founder in a boardroom, I’m reminded that at the heart of both lies a story—a story of hope, resilience, and the relentless pursuit of better outcomes. That’s what makes this journey so profoundly rewarding.